UT Southwestern researchers investigate high-risk populations for bladder-cancer screenings

	Tweet

A new study by UT Southwestern Medical Center researchers sheds light on the challenges involved in identifying which high-risk population would benefit most from bladder-cancer screening.

Large-scale screening of people at high risk for developing invasive bladder cancer could result in earlier diagnosis and improved survival rates. Bladder cancer is the fourth most common cancer in men and the fifth most common cancer overall. In the early stages of the disease, it’s common to have no signs or symptoms. Smoking has been proven to increase the risk of the disease.

“At this time bladder cancer screening is not the standard of care,” said Dr. Yair Lotan, associate professor of urology and senior author of the study appearing online and in a future edition of The Journal of Urology. “Although progress has been made in diagnosis, those efforts have translated into minimal survival benefit. In order to get the most benefit from the added cost of screening, we need to identify the appropriate population to screen.”

In the study researchers used a point-of-care urine-based test called NMP22 BladderChek to screen 1,502 subjects without symptoms who are at high risk for bladder cancer based on age, smoking history and occupational exposure.

Patients for the study were recruited from well-patient clinics at UT Southwestern and the Dallas Veterans Affairs Health Care System from March 2006 to November 2007. Those selected were over 50 years old, had smoked for 10 years or more, or had worked for 15 years or more in a high-risk occupation, such as in the dye, petroleum or chemical industries. Participants with other conditions that might lead to false-positive tests were excluded from the study.

Of the 1,502 participants, 85 tested positive for proteins that indicate the possible presence of a bladder tumor; 69 of those agreed to undergo cystoscopy. Only two, however, were found to have noninvasive bladder cancer. The majority of these participants had undergone urinalysis within three years of screening. At the one-year follow-up, two more were found to have cancer, and these patients were over 60 and had more than 42 pack-years of smoking.

“We did expect to find more cases,” Dr. Lotan said. “The significance is that even with high-risk patients, only a few had cancer. What that means is we need to find a higher-risk group either by increasing screening to over the age of 60 instead of 50 or looking at individuals with a longer smoking history.”

Dr. Lotan said that abstaining from or quitting smoking is the most effective way to prevent bladder cancer and that people should see a urologist immediately if they see blood in their urine or are found to have microscopic blood in their urine.

###

Other UT Southwestern researchers involved in the study were Dr. Arthur Sagalowsky, professor of urology; Dr. Brett Moran, associate professor of internal medicine; Dr. Geoffrey Nuss, urology resident; Dr. Aditya Bagrodia, family practice resident; Keren Elias, research study coordinator; and Dr. Robert Svatek, a fellow in urologic oncology at UT M.D. Andersen Cancer Center.

Visit http://www.utsouthwestern.org/cancercenter to learn more about UT Southwestern’s clinical services in cancer.

This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via e-mail, subscribe at http://www.utsouthwestern.edu/receivenews

Dr. Yair Lotan—http://www.utsouthwestern.edu/findfac/professional/0,2356,59883,00.html

Contact: Erin Prather Stafford

214-648-3404
UT Southwestern Medical Center

RELATED STORIES:
Arsenic cancer risk still high decades later in Chile region   Cholesterol drug inhibits cancer cells in lab   Survival and Response to Therapy of Non-Invasive Bladder Cancer Patients   Stanford computer algorithm used to identify bladder cancer marker   MDCT Shows Potential for Detecting Bladder Cancer Without Surgery or Contrast   Thomas Jefferson University Hospital adopts new imaging agent to improve detection of bladder cancer   New Biomarker Test Could Predict Outcome for Bladder Cancer Patients   Sales jobs tied to bladder cancer risk   AUA releases new guidelines on non-muscle invasive bladder cancer   Not enough evidence for bladder cancer screening   Women in nursing homes often have bladder problems   New Bladder Cancer Therapy for Patients Unresponsive to Standard Treatment   Early menopause related to bladder cancer risk   Bladder cancer: A difficult problem?   Bladder Cancer Study Determines Optimal Treatment   Extract of broccoli sprouts may protect against bladder cancer   New treatment option studied for bladder cancer   Less bladder cancer in frequent painkiller users   Radiation does not improve survival for rare, invasive bladder cancer   Genetic analysis may predict risk of invasive bladder cancer   Brochure Helps Patients Understand Treatments for Bladder Cancer   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]